International Conference on Nanotechnology in Drug Delivery
ICNDD
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest advancements in the design and optimization of nano-drug delivery systems. Researchers are invited to present their findings on novel formulations and methodologies that enhance therapeutic efficacy.
SDG 3
SDG 4
This session will explore various nanoparticle formulations aimed at targeted drug delivery, particularly in cancer therapy. Discussions will include the mechanisms of action and the effectiveness of these formulations in clinical settings.
SDG 3
SDG 9
This track examines the role of smart materials in enhancing drug delivery systems through responsive and adaptive mechanisms. Contributions will highlight the integration of nanotechnology with smart materials for improved therapeutic outcomes.
SDG 3
SDG 9
This session will delve into the latest developments in gene delivery systems utilizing nanotechnology. Researchers will discuss the optimization and adaptation of these systems for various therapeutic applications.
SDG 3
SDG 4
This track focuses on the innovative strategies for the delivery of small interfering RNA using nanoparticles. Presentations will cover the design, efficacy, and potential clinical applications of siRNA delivery systems.
SDG 3
SDG 4
This session will explore the use of nanoparticles in targeting angiogenesis, a critical process in tumor growth. Researchers will present their findings on the mechanisms and effectiveness of nanoparticle-based therapies.
SDG 3
SDG 9
This track addresses the application of nanosystems in managing inflammatory diseases. Contributions will focus on the design and efficacy of nanoparticle-based therapies in modulating inflammatory responses.
SDG 3
SDG 4
This session will investigate the toxicological effects and hazards associated with nanoparticles in drug delivery. Researchers will present evidence and discuss the implications of nanoparticle toxicity on health and safety.
SDG 3
SDG 4
This track focuses on the identification and targeting of cellular and intracellular sites for nanoparticle delivery. Discussions will include strategies to enhance cellular uptake and therapeutic efficacy.
SDG 3
SDG 4
This session will explore various routes of nano-drug delivery, including oral, intravenous, and localized delivery systems. Researchers are encouraged to share insights on the advantages and limitations of each route.
SDG 3
SDG 4
This track will address the regulatory and ethical challenges associated with the development and application of nanotechnology in drug delivery. Discussions will focus on ensuring safety and efficacy in clinical practice.
SDG 3
SDG 16